Minimal Access Surgical Technique (MAST) in Obese Patients in Degenerative Lumbar Disease. A Prospective Long-term Evaluation

September 21, 2017 updated by: Dr. Wolfgang Senker

Minimal Access Surgical Technique (MAST) in Obese Patients in Degenerative Lumbar Disease. A Prospective Long-term Evaluation.

Being confronted more and more with obese as well as older patients, minimally invasive surgery is said to keep the surgical trauma low. The prospective long-term evaluation is the continuous monitoring of patients undergoing lumbar minimally invasive fusion surgery and analyzing the effect of body mass index (BMI) and wound healing.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

187

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Amstetten, Austria
        • General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All patients who will undergo minimal access surgical technige for degenerative lumbar disease fusion

Description

  • All patients who will undergo minimally access surgical technique for degenerative lumbar disease fusion surger
  • Patient willing to participate in observational study and who signs patient information and patient consent form
  • patient older that 18 years
  • all products will be used within intended use

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
BMI < 25
Body Mass Index (BMI) according to WHO definition. BMI < 25 is defined as 'normal weight'.
25 <= BMI < 30
Body Mass Index (BMI) according to WHO definition. BMI >= 25 and < 30 is defined as 'overweight'.
BMI >= 30
Body Mass Index (BMI) according to WHO definition. BMI >= 30 is defined as 'obese'.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Operation related complications
Time Frame: between operation and hospital discharge of patient
between operation and hospital discharge of patient
Post operative fever
Time Frame: between operation and hospital discharge of patient
between operation and hospital discharge of patient
Liquor leakage
Time Frame: between operation and hosital discharge of patient
between operation and hosital discharge of patient

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wolfgang Senker, MD, General Hospital Amstetten

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2011

Primary Completion (Actual)

February 1, 2017

Study Completion (Actual)

February 1, 2017

Study Registration Dates

First Submitted

December 14, 2010

First Submitted That Met QC Criteria

December 14, 2010

First Posted (Estimate)

December 15, 2010

Study Record Updates

Last Update Posted (Actual)

September 25, 2017

Last Update Submitted That Met QC Criteria

September 21, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 2-Senker

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Degenerative Lumbar Disease

Subscribe